Ikena Oncology, Inc.IKNANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank29
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-54.14M
↓ 13% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-47.99M
Historical baseline
PeriodValueYoY Change
TTM$-54.14M-11.4%
2024$-48.59M+34.7%
2023$-74.40M-6.0%
2022$-70.15M-108.8%
2021$-33.59M+24.0%
2020$-44.22M-140.7%
2019$-18.37M+54.6%
2018$-40.44M-